热门资讯> 正文
Embecta Gets FDA Clearance for Disposable Insulin Patch Pump for Diabetes
2024-09-03 23:37
11:37 AM EDT, 09/03/2024 (MT Newswires) -- Embecta (EMBC) said Tuesday it has received the US Food and Drug Administration's 510(k) clearance for disposable patch pump for insulin delivery for the treatment of both type 1 and type 2 diabetes.
The system features a tubeless patch pump with a 300-unit insulin reservoir and a secured controller equipped with Bluetooth technology for a user-friendly interface and experience.
Embecta's said its patch pump development program also includes plans to introduce a closed-loop version featuring an insulin-dosing algorithm in a future FDA submission.
Shares of Embecta were up 2.3% in recent Tuesday trading.
Price: 16.72, Change: +0.38, Percent Change: +2.33
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
